News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
1600
Sources here
22
Companies here
22
Search results Stored financial headlines

Active search

1600 matching headlines

Ticker or company: STRAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Wealthcare Advisory Partners LLC Purchases Shares of 12,112 Astrazeneca Plc $AZN

Wealthcare Advisory Partners LLC acquired 12,112 shares of AstraZeneca Plc, valued at approximately $2.3 million, in the second quarter. This move is part of a broader trend of institutional investors increasing their holdings in the pharmaceutical company, which now has 20.35% institutional ownership. AstraZeneca …

AZN main company
Sharemaestro market context Price below Trend Line 52 weeks -1.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call

5 Must-Read Analyst Questions From Astrana Health's Q2 Earnings Call Astrana Health's second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw continued demand from payer and provider partners, maturation of value-based care cohorts, …

ASTH main company
Sharemaestro market context Trend signal active 52 weeks +33.0% ASTH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Angel Oak Financial Strategies Income Term Trust offers 10.39% yield but faces sustainability concerns due to weak coverage and volatility.

Angel Oak Financial Strategies Income Term Trust (FINS) offers a high distribution yield of 10.39% and exposure to investment-grade floating-rate community bank debt. However, its weak coverage and return of capital practices raise concerns about long-term sustainability. The fund's leverage and discount/premium fluctuations also …

FINS main company
Sharemaestro market context Trend signal started 52 weeks +4.7% · Next-week setup positive 56.8% FINS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insurance Australia Group Ltd (IAUGF) (FY 2026) Earnings Call Highlights: Strong Premium Growth ...

This article first appeared on GuruFocus. Premiums: Grew 7.6% to $18.4 billion, including a 10-month contribution from RACQ; underlying growth was around 2%. Underlying Insurance Profit: Up 2.3% to nearly $1.6 billion ($1.58 billion). Net Profit After Tax: Just over $1 billion. Final Dividend: …

IAG main company
Sharemaestro market context Trend signal active 52 weeks -4.5% · Next-week setup positive 58.5% IAG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Hold" by Analysts

Kestra Medical Technologies (NASDAQ:KMTS) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $28.14, aligning closely with its current stock price. Despite missing quarterly earnings estimates, the company's stock opened at $28.00, and analysts project a full-year loss …

KMTS main company
Sharemaestro market context Trend signal started 52 weeks +50.8% KMTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does Strong Q2 Results And Hedging Strategy Change The Bull Case For Vistra (VST)?

Vistra Corp. (VST) has reported strong Q2 2026 results, reaffirming its 2026 adjusted EBITDA guidance and noting nearly fully hedged 2026 generation volumes. While these factors strengthen near-term earnings visibility and the bull case for reliability, ongoing risks related to high leverage, commodity volatility, …

VST main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% · Next-week setup positive 56.7% VST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Australia's Telstra posts 3.2% rise in annual profit, unveils further $706 million buyback

Aug 13 (Reuters) - Australia's Telstra Group announced an additional share buyback of up to A$1 billion ($705.90 ‌million) on Thursday and reported a 3.2% rise ‌in annual profit, driven by growth in its mobile business and higher ​customer spending. The telecom firm posted …

TLS main company
Sharemaestro market context Price below Trend Line 52 weeks -1.5% · Next-week setup positive 56.4% TLS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mistras: My Little Stock Pick Grew Up (NYSE:MG)

Mistras Group, Inc. (MG) has delivered strong results, driven by successful diversification and execution of its "Vision 2030." The company raised its full-year revenue and adjusted EBITDA guidance, reflecting accelerated growth and improved profitability. The author reiterates a Buy rating with a $26 price …

MG main company
Sharemaestro market context Trend signal started 52 weeks +88.3% MG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mistras Group Releases Q2 2026 Financial Results

Mistras Group, Inc. reported stronger-than-expected Q2 2026 financial results, with non-GAAP earnings per share of $0.28, surpassing Wall Street estimates by 16.7%. The company achieved $193.1 million in revenue, a 4.2% increase year-over-year, driven primarily by its Oil & Gas segment. Analysts maintain a …

MG main company
Sharemaestro market context Trend signal started 52 weeks +88.3% MG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vistra Corp. stock outperforms competitors on strong trading day

Vistra Corp. (VST) saw its stock rise by 1.21% to $146.68 on Wednesday, marking its third consecutive day of gains. This performance occurred on a mixed trading day where the S&P 500 Index increased by 0.26%, while the Dow Jones Industrial Average fell by …

VST main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% · Next-week setup positive 56.7% VST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context